Cardiovascular complications and its impact on outcomes in COVID-19: An original research
Introduction: The viral infection COVID-19 is highly infectious and has claimed many lives till date and is still continuing to consume lives. In the COVID-19, along with pulmonary symptoms, cardiovascular (CV) events were also recorded that have known to significantly contribute to the mortality. I...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wolters Kluwer Medknow Publications
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/858dc58d59864eddbe68294b86802d78 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:858dc58d59864eddbe68294b86802d78 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:858dc58d59864eddbe68294b86802d782021-11-19T12:15:52ZCardiovascular complications and its impact on outcomes in COVID-19: An original research0975-740610.4103/jpbs.jpbs_143_21https://doaj.org/article/858dc58d59864eddbe68294b86802d782021-01-01T00:00:00Zhttp://www.jpbsonline.org/article.asp?issn=0975-7406;year=2021;volume=13;issue=6;spage=1333;epage=1337;aulast=Kumarhttps://doaj.org/toc/0975-7406Introduction: The viral infection COVID-19 is highly infectious and has claimed many lives till date and is still continuing to consume lives. In the COVID-19, along with pulmonary symptoms, cardiovascular (CV) events were also recorded that have known to significantly contribute to the mortality. In our study, we designed and validated a new risk score that can predict CV events, and also evaluated the effect of these complications on the prognosis in COVID-19 patients. Materials and Methods: A retrospective, multicenter, observational study was done among 1000 laboratory-confirmed COVID-19 patients between June 2020 and December 2020. All the data of the clinical and laboratory parameters were collected. Patients were randomly divided into two groups for testing and validating the hypothesis. The identification of the independent risk factors was done by the logistic regression analysis method. Results: Of all the types of the clinical and laboratory parameters, ten “independent risk factors” were identified associated with CV events in Group A: male gender, older age, chronic heart disease, cough, lymphocyte count <1.1 × 109/L at admission, blood urea nitrogen >7 mmol/L at admission, estimated glomerular filtration rate <90 ml/min/1.73 m2 at admission, activated partial thromboplastin time >37 S, D-dimer, and procalcitonin >0.5 mg/L. In our study, we found that CV events were significantly related with inferior prognosis (P < 0.001). Conclusions: A new risk scoring system was designed in our study, which may be used as a predictive tool for CV complications among the patients with COVID-19 infection.Prashant KumarKaousthubh TiwariSiva Kumar PendyalaRatnesh Kumar JaiswalNeelathil Lisa ChackoEkta SrivastavaRahul V C TiwariWolters Kluwer Medknow Publicationsarticlecardiovascular eventscovid-19scoring systemPharmacy and materia medicaRS1-441Analytical chemistryQD71-142ENJournal of Pharmacy and Bioallied Sciences, Vol 13, Iss 6, Pp 1333-1337 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
cardiovascular events covid-19 scoring system Pharmacy and materia medica RS1-441 Analytical chemistry QD71-142 |
spellingShingle |
cardiovascular events covid-19 scoring system Pharmacy and materia medica RS1-441 Analytical chemistry QD71-142 Prashant Kumar Kaousthubh Tiwari Siva Kumar Pendyala Ratnesh Kumar Jaiswal Neelathil Lisa Chacko Ekta Srivastava Rahul V C Tiwari Cardiovascular complications and its impact on outcomes in COVID-19: An original research |
description |
Introduction: The viral infection COVID-19 is highly infectious and has claimed many lives till date and is still continuing to consume lives. In the COVID-19, along with pulmonary symptoms, cardiovascular (CV) events were also recorded that have known to significantly contribute to the mortality. In our study, we designed and validated a new risk score that can predict CV events, and also evaluated the effect of these complications on the prognosis in COVID-19 patients. Materials and Methods: A retrospective, multicenter, observational study was done among 1000 laboratory-confirmed COVID-19 patients between June 2020 and December 2020. All the data of the clinical and laboratory parameters were collected. Patients were randomly divided into two groups for testing and validating the hypothesis. The identification of the independent risk factors was done by the logistic regression analysis method. Results: Of all the types of the clinical and laboratory parameters, ten “independent risk factors” were identified associated with CV events in Group A: male gender, older age, chronic heart disease, cough, lymphocyte count <1.1 × 109/L at admission, blood urea nitrogen >7 mmol/L at admission, estimated glomerular filtration rate <90 ml/min/1.73 m2 at admission, activated partial thromboplastin time >37 S, D-dimer, and procalcitonin >0.5 mg/L. In our study, we found that CV events were significantly related with inferior prognosis (P < 0.001). Conclusions: A new risk scoring system was designed in our study, which may be used as a predictive tool for CV complications among the patients with COVID-19 infection. |
format |
article |
author |
Prashant Kumar Kaousthubh Tiwari Siva Kumar Pendyala Ratnesh Kumar Jaiswal Neelathil Lisa Chacko Ekta Srivastava Rahul V C Tiwari |
author_facet |
Prashant Kumar Kaousthubh Tiwari Siva Kumar Pendyala Ratnesh Kumar Jaiswal Neelathil Lisa Chacko Ekta Srivastava Rahul V C Tiwari |
author_sort |
Prashant Kumar |
title |
Cardiovascular complications and its impact on outcomes in COVID-19: An original research |
title_short |
Cardiovascular complications and its impact on outcomes in COVID-19: An original research |
title_full |
Cardiovascular complications and its impact on outcomes in COVID-19: An original research |
title_fullStr |
Cardiovascular complications and its impact on outcomes in COVID-19: An original research |
title_full_unstemmed |
Cardiovascular complications and its impact on outcomes in COVID-19: An original research |
title_sort |
cardiovascular complications and its impact on outcomes in covid-19: an original research |
publisher |
Wolters Kluwer Medknow Publications |
publishDate |
2021 |
url |
https://doaj.org/article/858dc58d59864eddbe68294b86802d78 |
work_keys_str_mv |
AT prashantkumar cardiovascularcomplicationsanditsimpactonoutcomesincovid19anoriginalresearch AT kaousthubhtiwari cardiovascularcomplicationsanditsimpactonoutcomesincovid19anoriginalresearch AT sivakumarpendyala cardiovascularcomplicationsanditsimpactonoutcomesincovid19anoriginalresearch AT ratneshkumarjaiswal cardiovascularcomplicationsanditsimpactonoutcomesincovid19anoriginalresearch AT neelathillisachacko cardiovascularcomplicationsanditsimpactonoutcomesincovid19anoriginalresearch AT ektasrivastava cardiovascularcomplicationsanditsimpactonoutcomesincovid19anoriginalresearch AT rahulvctiwari cardiovascularcomplicationsanditsimpactonoutcomesincovid19anoriginalresearch |
_version_ |
1718420143844884480 |